KMT2A are highly pathogenic leukemic drivers, revealed by the high incidence of KMT2A-rearangements in ALL in infants, with few cooperative mutations associated with leukaemia [1]. This evidence concerns the gene KMT2A and acute lymphoblastic leukemia.